サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1404819

ヒアルロン酸ナトリウムベースの製品市場規模、シェア、動向分析レポート：タイプ別、用途別｛医薬品、化粧品｝、地域別、セグメント別予測、2023年～2030年

Sodium Hyaluronate-based Products Market Size, Share & Trends Analysis Report By Type (Injectable, Topical), By Application {Pharmaceuticals (Orthopedic, Ophthalmology, Urology), Cosmetics}, By Region, And Segment Forecasts, 2023 - 2030
出版日: | 発行: Grand View Research | ページ情報: 英文 120 Pages | 納期: 2～10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
ヒアルロン酸ナトリウムベースの製品市場規模、シェア、動向分析レポート：タイプ別、用途別｛医薬品、化粧品｝、地域別、セグメント別予測、2023年～2030年
出版日: 2023年11月29日
発行: Grand View Research
ページ情報: 英文 120 Pages
納期: 2～10営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

ヒアルロン酸ナトリウムベースの製品市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界のヒアルロン酸ナトリウムベースの製品市場規模は、2023年から2030年にかけて7.7%のCAGRを記録し、2030年には177億3,000万米ドルに達すると予測されています。

市場成長の要因は、高齢者人口の増加、変形性関節症や白内障の高い有病率、技術の進歩、意識の高まり、非侵襲的な美容施術の世界の増加などです。

主に世界の高齢化人口の増加により、老化の兆候を回復させるアンチエイジング化粧品や美容トリートメントの需要が増加しています。ヒアルロン酸ナトリウム（NaHA）は、ヒアルロン酸よりも溶解性が高く、分子が小さく皮膚への浸透性が高いです。シワを埋め、より若々しい外見を取り戻すために皮膚の領域に注入される真皮充填剤に、ますます使用されるようになってきています。市場で入手可能なFDA認可のヒアルロン酸ナトリウム皮膚充填剤には、Restylane Defyne、Refyne、Restylaneなどがあります。したがって、このような製品に対するニーズは、予測期間中、ヒアルロン酸ナトリウムベースの製品にとってインパクトのあるレンダリング 促進要因として作用すると予想されます。

WHOは、2050年までに60歳以上の世界人口の推定15％が症候性変形性関節症に苦しむと予測しています。高齢化とともに、肥満や座りっぱなしのライフスタイルなど他の危険因子の増加が、この問題をさらに悪化させると予想されています。前述の要因と、これらの症状の治療におけるヒアルロン酸ナトリウム製品の有効性により、その市場は予測期間中に大きく成長すると予想されます。

ヒアルロン酸ナトリウムベースの製品は大きな利点を提供するが、その高価な性質のため、特定の患者グループには手が届かないこともあります。例えば、米国におけるNaHA注射の平均価格は350～800ドルです。さらに、ヒアルロン酸ナトリウム皮膚充填剤から得られる特典は一時的なものであり、最大18ヵ月持続し、所望の効果を維持するためにはさらなる維持治療が必要となり、追加費用が発生します。ヒアルロン酸の単相製品や二重製品は高価格製品であるため、すべての患者が利用できるわけではないです。その高価格は主に高い製造コストを反映しています。

さらに、SARS-CoV-2の流行はヒアルロン酸ナトリウム市場に大きな影響を与えました。世界の外科手術件数の減少とサプライチェーンの混乱は、ヒアルロン酸ナトリウムベースの製品に対する世界の需要を減少させました。

主要企業は、新製品発売や戦略的パートナーシップのような複数の戦略を活用し、製品ポートフォリオを拡大することで、より競争力のある製品群を揃えています。例えば、2020年、生化学工業株式会社とエーザイ株式会社は、韓国におけるSI-613（ジクロフェナク結合ヒアルロン酸ナトリウム）の販売提携を結びました。本契約に基づき、エーザイ・コリア・インクは韓国におけるSI-613の独占的販売代理店となります。

ヒアルロン酸ナトリウムベースの製品市場レポートハイライト

  • 注射剤セグメントは、美容整形における皮膚充填剤、変形性関節症における疼痛緩和剤、白内障摘出における手術補助剤、婦人科手術における癒着防止剤など、幅広い用途があるため、2022年には90%以上の最大売上シェアを占めました。
  • 医薬品分野は、2022年に60％以上の最大の収益シェアを占め、様々な医薬品用途での高い使用率により、予測期間中に7.9％の最速CAGRで成長すると予測されています。
  • 北米は市場を独占し、2022年には35％を超える最大の収益シェアを占めました。これは、他の地域と比較して、ヘルスケア支出が高く、白内障や皮膚フィラー処置の数が多いためです。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 マイクロニードルドラッグデリバリーシステム市場の変数、動向および範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 普及と成長の見通しマッピング
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ヒアルロン酸ナトリウムベースの製品市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 ヒアルロン酸ナトリウムベースの製品：タイプの推定・動向分析

  • ヒアルロン酸ナトリウムベースの製品市場：主要ポイント
  • ヒアルロン酸ナトリウムベースの製品市場：動向と市場シェア分析、2022年および2030年
  • 局所
    • 局所市場推計・予測、2018年～2030年
  • 注射可能
    • 注射剤市場推計・予測、2018年～2030年
  • その他
    • その他の市場推計・予測、2018年～2030年

第5章 ヒアルロン酸ナトリウムベースの製品：用途の推定・動向分析

  • ヒアルロン酸ナトリウムベースの製品市場：主要ポイント
  • ヒアルロン酸ナトリウムベースの製品市場：動向と市場シェア分析、2022年および2030年
  • 医薬品
    • 医薬品市場推計・予測、2018年～2030年
  • 化粧品
    • 化粧品市場推計・予測、2018年～2030年

第6章 ヒアルロン酸ナトリウムベースの製品：地域別の推定・動向分析

  • 地域別の見通し
  • ヒアルロン酸ナトリウムベースの製品：主要ポイント
  • 北米
    • 市場推計・予測、2018年～2030年
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スウェーデン
    • ノルウェー
    • デンマーク
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • オーストラリア
    • タイ
    • 韓国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • サウジアラビア
    • 南アフリカ
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 市場参入企業の分類
    • Allergan, Inc.(a part of AbbVie, Inc.)
    • Galderma S.A.
    • Bohus BioTech AB
    • LG Chem Ltd.
    • Syner-Med (Pharmaceutical Products) Ltd.
    • Anika Therpeutics Inc.
    • Cadila Pharmaceuticals Ltd.
    • Ferring Pharmaceuticals B.V.
    • Fidia Farmaceutici S.p.A.
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 5 U.S. sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 6 Canada sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 7 Canada sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 8 Europe sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 9 Europe sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 10 Europe sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 11 Germany sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 12 Germany sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 13 UK sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 14 UK sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 15 France sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 16 France sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 17 Italy sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 18 Italy sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 19 Spain sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 20 Spain sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 21 Sweden sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 22 Sweden sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 23 Norway sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 24 Norway sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 25 Denmark sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 26 Denmark sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 27 Asia Pacific sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 28 Asia Pacific sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 29 Asia Pacific sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 30 China sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 31 China sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 32 Japan sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 33 Japan sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 34 India sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 35 India sodium hyaluronate-based products market, by application, (USD Million) 2018 - 2030
  • Table 36 Australia sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 37 Australia sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 38 Thailand sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 39 Thailand sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 40 South Korea sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 41 South Korea sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 42 Latin America sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 43 Latin America sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 44 Latin America sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 45 Brazil sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 46 Brazil sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 47 Mexico sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 48 Mexico sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 49 Argentina sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 50 Argentina sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 51 Middle East and Africa sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 52 Middle East and Africa sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 53 Middle East and Africa sodium hyaluronate-based products market, by region, 2018 - 2030 (USD Million)
  • Table 54 South Africa sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Africa sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 56 Saudi Arabia sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 57 Saudi Arabia sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 58 UAE sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 59 UAE sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)
  • Table 60 Kuwait sodium hyaluronate-based products market, by type, 2018 - 2030 (USD Million)
  • Table 61 Kuwait sodium hyaluronate-based products market, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Microneedle drug delivery systems: Market outlook
  • Fig. 9 Microneedle drug delivery systems: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Sodium hyaluronate-based products market driver impact
  • Fig. 15 Sodium hyaluronate-based products market restraint impact
  • Fig. 16 Sodium hyaluronate-based products market strategic initiatives analysis
  • Fig. 17 Sodium hyaluronate-based products market: Type movement analysis
  • Fig. 18 Sodium hyaluronate-based products market: Type outlook and key takeaways
  • Fig. 19 Topical market estimates and forecasts, 2018 - 2030
  • Fig. 20 Injectable market estimates and forecasts, 2018 - 2030
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030
  • Fig. 22 Sodium hyaluronate-based products market: Application movement analysis
  • Fig. 23 Sodium hyaluronate-based products market: Application outlook and key takeaways
  • Fig. 24 Pharmaceutical market estimates and forecasts, 2018 - 2030
  • Fig. 25 Cosmetics market estimates and forecasts, 2018 - 2030
  • Fig. 26 Global sodium hyaluronate-based products market: Regional movement analysis
  • Fig. 27 Global sodium hyaluronate-based products market: Regional outlook and key takeaways
  • Fig. 28 North America market estimates and forecasts, 2018 - 2030
  • Fig. 29 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 30 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 31 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 32 UK market estimates and forecasts, 2018 - 2030
  • Fig. 33 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 34 France market estimates and forecasts, 2018 - 2030
  • Fig. 35 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 36 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 37 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 38 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 39 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 40 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 41 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 42 China market estimates and forecasts, 2018 - 2030
  • Fig. 43 India market estimates and forecasts, 2018 - 2030
  • Fig. 44 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 45 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 46 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 47 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 48 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 49 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 50 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 51 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 53 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 54 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 55 Kuwait market estimates and forecasts, 2018 - 2030
目次
Product Code: GVR-4-68038-345-4

Sodium Hyaluronate-based Products Market Growth & Trends:

The global sodium hyaluronate-based products market size is expected to reach USD 17.73 billion by 2030, registering a CAGR of 7.7% from 2023 to 2030, according to a new report by Grand View Research, Inc. The market growth is attributed to factors such as the increasing geriatric population, a high prevalence of osteoarthritis and cataracts, technological advancements, rising awareness, and a growing number of non-invasive aesthetic procedures globally.

The demand for antiaging cosmetics and aesthetic treatments, which help people in reversing their aging signs, is increasing, mainly due to a global increase in the aging population. Sodium hyaluronate (NaHA) is more soluble than hyaluronic acid, along with having smaller molecules and greater skin penetration. It is increasingly being used in dermal fillers that are injected into areas of the skin to fill out wrinkles and help restore a more youthful appearance. Some of the FDA-approved sodium hyaluronate dermal fillers available in the market are Restylane Defyne, Refyne, and Restylane. Thus, it is anticipated that the need for such products will act as a high-impact rendering driver for sodium hyaluronate-based products over the forecast period.

The WHO predicts that by 2050, an estimated 15% of the world's population above the age of 60 years will suffer from symptomatic osteoarthritis. Along with the aging population, an increase in other risk factors such as obesity and a sedentary lifestyle is expected to further exacerbate the problem. Due to the aforementioned factors and the effectiveness of sodium hyaluronate products in treating these conditions, its market is expected to grow significantly over the forecast period.

Although sodium hyaluronate-based products offer major benefits, due to their expensive nature, they can be out of reach for certain patient groups. For instance, the average price of NaHA injections in the U.S. ranges from USD 350 to USD 800. Moreover, benefits derived from sodium hyaluronate dermal fillers are temporary, lasting up to 18 months and requiring further upkeep treatments to maintain the desired effect, leading to additional expenses. Single-phase products and duplex products of hyaluronic acid are premium-priced products, and thus, they are not accessible to all patients. Their high price primarily reflects high manufacturing costs.

Moreover, the SARS-CoV-2 pandemic has substantially impacted the sodium hyaluronate market. A decrease in the number of surgical procedures worldwide and disruptions in the supply chain have reduced the demand for sodium hyaluronate-based products worldwide.

Key players are leveraging multiple strategies such as new product launches and strategic partnerships to expand their product portfolio, and thereby, have a more competitive range of offerings. For instance, in 2020, Seikagaku Corporation and Eisai Co., Ltd. formed a marketing alliance for SI-613 (diclofenac-conjugated sodium hyaluronate) in South Korea. Based on this agreement, Eisai Korea, Inc. will be the exclusive distributor of SI-613 in South Korea.

Sodium Hyaluronate-based Products Market Report Highlights:

  • The injectable segment accounted for the largest revenue share of over 90% in 2022 owing to a wide range of applications, such as dermal fillers in cosmetic procedures, pain relief in osteoarthritis, surgical aids in cataract extractions, and anti-adhesives in gynecological operations
  • The pharmaceutical segment held the largest revenue share of over 60% in 2022 and is anticipated to grow at the fastest CAGR of 7.9% over the forecast period owing to the high usage in a variety of pharmaceutical applications
  • North America dominated the market and accounted for the largest revenue share of over 35% in 2022 due to the higher healthcare expenditure and a greater number of cataract and dermal filler procedures as compared to other regions

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. Regional scope
    • 1.1.4. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Microneedle Drug Delivery Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Sodium Hyaluronate - Based Products Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Sodium Hyaluronate-Based Products: Type Estimates & Trend Analysis

  • 4.1. Sodium Hyaluronate-Based Products Market: Key Takeaways
  • 4.2. Sodium Hyaluronate-Based Products Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Topical
    • 4.3.1. Topical market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.4. Injectable
    • 4.4.1. Injectable market estimates and forecast, 2018 - 2030 (USD Million)
  • 4.5. Others
    • 4.5.1. Others market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 5. Sodium Hyaluronate-Based Products: Applications Estimates & Trend Analysis

  • 5.1. Sodium Hyaluronate-Based Products Market: Key Takeaways
  • 5.2. Sodium Hyaluronate-Based Products Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Pharmaceuticals
    • 5.3.1. Pharmaceuticals market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.1. Ophthalmic
      • 5.3.1.1.1. Ophthalmic market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.2. Orthopedic
      • 5.3.1.2.1. Ophthalmic market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.3. Urology
      • 5.3.1.3.1. Urology market estimates and forecast, 2018 - 2030 (USD Million)
      • 5.3.1.4. Others
      • 5.3.1.4.1. Others market estimates and forecast, 2018 - 2030 (USD Million)
  • 5.4. Cosmetics
    • 5.4.1. Cosmetics market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 6. Sodium Hyaluronate-Based Products: Regional Estimates & Trend Analysis

  • 6.1. Regional Outlook
  • 6.2. Sodium Hyaluronate-Based Products: Key Takeaway
  • 6.3. North America
    • 6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.2. U.S.
      • 6.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.3.3. Canada
      • 6.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.3. France
      • 6.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.6. Sweden
      • 6.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.7. Norway
      • 6.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. Japan
      • 6.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.2. China
      • 6.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.3. India
      • 6.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.5. Thailand
      • 6.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.5.6. South Korea
      • 6.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.6. Latin America
    • 6.6.1. Brazil
      • 6.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.2. Mexico
      • 6.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.6.3. Argentina
      • 6.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 6.7. MEA
    • 6.7.1. Saudi Arabia
      • 6.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.2. South Africa
      • 6.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.3. UAE
      • 6.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 6.7.4. Kuwait
      • 6.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Market Participant Categorization
    • 7.2.1. Allergan, Inc.(a part of AbbVie, Inc.)
      • 7.2.1.1. Company overview
      • 7.2.1.2. Financial performance
      • 7.2.1.3. Product benchmarking
      • 7.2.1.4. Strategic initiatives
    • 7.2.2. Galderma S.A.
      • 7.2.2.1. Company overview
      • 7.2.2.2. Financial performance
      • 7.2.2.3. Product benchmarking
      • 7.2.2.4. Strategic initiatives
    • 7.2.3. Bohus BioTech AB
      • 7.2.3.1. Company overview
      • 7.2.3.2. Financial performance
      • 7.2.3.3. Product benchmarking
      • 7.2.3.4. Strategic initiatives
    • 7.2.4. LG Chem Ltd.
      • 7.2.4.1. Company overview
      • 7.2.4.2. Financial performance
      • 7.2.4.3. Product benchmarking
      • 7.2.4.4. Strategic initiatives
    • 7.2.5. Syner-Med (Pharmaceutical Products) Ltd.
      • 7.2.5.1. Company overview
      • 7.2.5.2. Financial performance
      • 7.2.5.3. Product benchmarking
      • 7.2.5.4. Strategic initiatives
    • 7.2.6. Anika Therpeutics Inc.
      • 7.2.6.1. Company overview
      • 7.2.6.2. Financial performance
      • 7.2.6.3. Product benchmarking
      • 7.2.6.4. Strategic initiatives
    • 7.2.7. Cadila Pharmaceuticals Ltd.
      • 7.2.7.1. Company overview
      • 7.2.7.2. Financial performance
      • 7.2.7.3. Product benchmarking
      • 7.2.7.4. Strategic initiatives
    • 7.2.8. Ferring Pharmaceuticals B.V.
      • 7.2.8.1. Company overview
      • 7.2.8.2. Financial performance
      • 7.2.8.3. Product benchmarking
      • 7.2.8.4. Strategic initiatives
    • 7.2.9. Fidia Farmaceutici S.p.A.
      • 7.2.9.1. Company overview
      • 7.2.9.2. Financial performance
      • 7.2.9.3. Product benchmarking
      • 7.2.9.4. Strategic initiatives